News

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

April 18, 2016

Martin Kampmann, PhD, Assistant Professor at the Institute for Neurodegenerative Diseases, UCSF, receives $750,000 research award for his project, "'Weak links' in cancer proteostasis networks as new therapeutic targets."

Gene Mutation Makes Tumors Tense, Worsens Patient Prognosis

Gene Mutation Makes Tumors Tense, Worsens Patient Prognosis

April 18, 2016

UC San Francisco researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.

New Cancer Immunotherapy Clinic Offers Unique Studies of Promising Treatments

New Cancer Immunotherapy Clinic Offers Unique Studies of Promising Treatments

April 12, 2016

UC San Francisco oncologist Lawrence Fong, MD, personifies the tremendous excitement among cancer physicians over the growing potential of new immunotherapies.

UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy

UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy

April 12, 2016

Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of theParker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, a private philanthropic organization established by Silicon Valley entrepreneur Sean Parker.

American Association for Cancer Research Elects UCSF Faculty to Board of Directors, Nominating Committee

American Association for Cancer Research Elects UCSF Faculty to Board of Directors, Nominating Committee

April 11, 2016

Congratulations to Alan Ashworth, PhD, and Jennifer Grandis, MD

Berger, Bluestone Named to White House Cancer Moonshot Expert Panel

Berger, Bluestone Named to White House Cancer Moonshot Expert Panel

April 6, 2016

Mitchel Berger, MD, and Jeff Bluestone, PhD, have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative.